Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold

Transfusion

Volumn 54, Issue 8, 2014, Pages 1935-1944

  Chan, Kasey Sze Kei ^a   Sparrow, Rosemary L ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; CD235A ANTIGEN; FIBRINOGEN; FIBRINOGEN RECEPTOR; FRESH FROZEN PLASMA; LYMPHOCYTE ANTIGEN; PHOSPHATIDYLSERINE; PROCOAGULANT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; DONOR; ERYTHROCYTE; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; MALE; MEMBRANE MICROPARTICLE; NORMAL HUMAN; REDUCTION; ROOM TEMPERATURE; THROMBOCYTE; THROMBOELASTOGRAPHY; WHOLE BLOOD LEUKOREDUCTION;

ADULT; BLOOD CELL COUNT; BLOOD PLATELETS; BLOOD PRESERVATION; CELL-DERIVED MICROPARTICLES; FACTOR VIII; FACTOR XIII; FIBRINOGEN; FILTRATION; FLOW CYTOMETRY; HEMOSTASIS; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; MEMBRANE LIPIDS; MIDDLE AGED; PHOSPHATIDYLSERINES; PLASMA; TEMPERATURE; THROMBELASTOGRAPHY;

EID: 84906100164     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12602     Document Type: Article

References (43)

1. Benjamin RJ, McLaughlin LS,. Plasma components: properties, differences, and uses. Transfusion 2012; 52 (Suppl 1): 9S-19S.
2. del Junco DJ, Holcomb JB, Fox EE, et al. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 2013; 75 (Suppl 1): S24-30.
3. Campion EM, Pritts TA, Dorlac WC, et al. Implementation of a military-derived damage-control resuscitation strategy in a civilian trauma center decreases acute hypoxia in massively transfused patients. J Trauma Acute Care Surg 2013; 75 (Suppl 2): S221-227.
4. Callum JL, Rizoli S,. Plasma transfusion for patients with severe hemorrhage: what is the evidence? Transfusion 2012; 52 (Suppl 1): 30S-37.
5. Farrah T, Deutsch EW, Omenn GS, et al. A high confidence human plasma proteome reference set with estimated concentrations in Peptide Atlas. Mol Cell Proteomics 2011; 10: M110.006353.
6. Cardigan R, Sutherland J, Garwood M, et al. The effect of leucocyte depletion on the quality of fresh-frozen plasma. Br J Haematol 2001; 114: 233-240.
7. Alhumaidan HS, Cheves TA, Holme S, et al. The effect of filtration on residual levels of coagulation factors in plasma. Am J Clin Pathol 2013; 139: 110-116.
8. Wilsher C, Garwood M, Sutherland J, et al. The effect of storing whole blood at 22 C for up to 24 hours with and without rapid cooling on the quality of red cell concentrates and fresh-frozen plasma. Transfusion 2008; 48: 2338-2347.
9. Singh S, Kumar A,. Leukocyte depletion for safe blood transfusion. Biotech J 2009; 4: 1140-1151.
10. Krailadsiri P, Seghatchian J, MacGregor I, et al. The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 2006; 46: 407-417.
11. Ohto H, Yasuda H, Yokota M, et al. HLA antibodies after transfusions of FFP. Transfusion 2000; 40: 613.
12. Heddle NM, Blajchman MA,. The leukodepletion of cellular blood products in the prevention of HLA-alloimmunization and refractoriness to allogeneic platelet transfusions. Blood 1995; 85: 603-606.
13. Rapaille A, Moore G, Siquet J, et al. Prestorage leukocyte reduction with in-line filtration of whole blood: evaluation of red cells and plasma storage. Vox Sang 1997; 73: 28-35.
14. Riggert J, Schwartz DW, Wieding JU, et al. Prestorage inline filtration of whole blood for obtaining white cell-reduced blood components. Transfusion 1997; 37: 1039-1044.
15. Heiden M, Salge U, Henschler R, et al. Plasma quality after whole-blood filtration depends on storage temperature and filter type. Transfus Med 2004; 14: 297-304.
16. European Directorate for the Quality of Medicines & HealthCare. Guide to the preparation, use and quality assurance of blood components: recommendation. 16th ed. Strasborg: Council of Europe Publishing; 2011.
17. Australian Red Cross Blood Service. Fresh frozen plasma. 2014 [cited 2014 Feb 27]. Available from: http://www.transfusion.com.au/blood-products/ components/plasma
18. AABB Standard Program Committee. Standards for blood banks and transfusion services. 28th ed. Bethesda (MD): American Association of Blood Banks; 2012.
19. Serrano K, Scammell K, Weiss S, et al. Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards. Transfusion 2010; 50: 344-353.
20. Cardigan R, van der Meer PF, Pergande C, et al. Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study. Transfusion 2011; 51 (Suppl 1): 50S-57.
21. Chudziak D, Sireis W, Pfeiffer HU, et al. Accumulation of soluble inflammatory mediators between blood donation and pre-storage leucocyte depletion. Vox Sang 2009; 96: 163-166.
22. Kretzschmar E, Kruse F, Greiss O, et al. Effects of extended storage of whole blood before leucocyte depletion on coagulation factors in plasma. Vox Sang 2004; 87: 156-164.
23. van der Meer PF, de Wildt-Eggen J,. The effect of whole-blood storage time on the number of white cells and platelets in whole blood and in white cell-reduced red cells. Transfusion 2006; 46: 589-594.
24. Sugawara A, Nollet KE, Yajima K, et al. Preventing platelet-derived microparticle formation-and possible side effects-with prestorage leukofiltration of whole blood. Arch Path. Lab Med 2010; 134: 771-775.
25. Shapiro S, Laffan M,. Making contact with microparticles. J Thromb Haemost 2012; 10: 1352-1354.
26. Zwicker JI, Trenor CC, Furie BC, et al. Tissue factor-bearing microparticles and thrombus formation. Arterioscler Thromb Vasc Biol 2011; 31: 728-733.
27. Théry C, Ostrowski M, Segura E,. Membrane vesicles as conveyers of immune responses. Nat Immunol Rev 2009; 9: 581-593.
28. Saddallah S, Eken C, Schifferli JA,. Ectosomes as immunmodulators. Semin Immunopathol 2011; 33: 487-495.
29. McVey M, Tabuchi A, Kuebler WM,. Microparticles and acute lung injury. Am J Physiol Lung Cell Mol Physiol 2012; 303: L364-381.
30. Sparrow RL, Chan KS,. Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations. J. Proteomics 2012; 76: 211-219.
31. Goodnough LT, Hill CC,. Use of point-of-care testing for plasma therapy. Transfusion 2012; 52 (Suppl 1): 56S-64S.
32. Hou J, Fu Y, Zhou J, et al. Lactadherin functions as a probe for phosphatidylserine exposure and as an anticoagulant in the study of stored platelets. Vox Sang 2011; 100: 187-195.
33. Eder AF, Dy BA, Perez JM, et al. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013; 53: 1442-1449.
34. Glenister KM, Sparrow RL,. Level of platelet-derived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter. Transfusion 2010; 50: 185-189.
35. Lawrie AS, Harrison P, Cardigan RA, et al. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma. Vox Sang 2008; 95: 197-204.
36. Van Der Meijden PE, Van Schilfgaarde M, Van Oerle R, et al. Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa. J Thromb Haemost 2012; 10: 1355-1362.
37. Griep MA, Fujikawa K, Nelsestuen GL,. Binding and activation properties of human factor XII, prekallikrein, and derived peptides with acidic lipid vesicles. Biochemistry 1985; 24: 4124-4130.
38. Naito K, Fujikawa K,. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 1991; 266: 7353-7358.
39. Huang M, Rigby AC, Morelli X, et al. Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol 2003; 10: 751-756.
40. Lawrie AS, Cardigan RA, Williamson LM, et al. The dynamics of clot formation in fresh-frozen plasma. Vox Sang 2008; 94: 306-314.
41. Ostrowski SR, Bochsen L, Wideløv NA, et al. Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion 2011; 51: 344-356.
42. Bochsen L, Johansson PI, Kristensen AT, et al. The influence of platelets, plasma and red blood cells on functional haemostatic assays. Blood Coagul Fibrinolysis 2011; 22: 167-175.
43. Urban R, Guillermo Couto C, Iazbik MC,. Evaluation of hemostatic activity of canine frozen plasma for transfusion by thromboelastography. J Vet Intern Med 2013; 27: 964-969.